Ifp Advisors, Inc 10x Genomics, Inc. Transaction History

Ifp Advisors, Inc

  • $2.42 Billion
  • Q2 2024

A detailed history of Ifp Advisors, Inc transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 33 shares of TXG stock, worth $495. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33
Previous 28 17.86%
Holding current value
$495
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024
BUY
$19.45 - $37.37 $97 - $186
5 Added 17.86%
33 $0
Q1 2023

Apr 18, 2023
SELL
$35.33 - $55.79 $1,625 - $2,566
-46 Reduced 62.16%
28 $1,000
Q4 2022

Feb 07, 2023
SELL
$24.4 - $41.3 $2,366 - $4,006
-97 Reduced 56.73%
74 $4,000
Q3 2022

Nov 08, 2022
BUY
$28.48 - $52.59 $56 - $105
2 Added 1.18%
171 $14,000
Q2 2022

Sep 06, 2022
BUY
$36.95 - $82.41 $6,244 - $13,927
169 New
169 $14,000
Q2 2022

Aug 12, 2022
SELL
$36.95 - $82.41 $6,244 - $13,927
-169 Closed
0 $0
Q1 2022

Sep 06, 2022
BUY
$55.7 - $145.79 $6,461 - $16,911
116 Added 218.87%
169 $12,000
Q1 2022

Aug 08, 2022
BUY
$55.7 - $145.79 $1,002 - $2,624
18 Added 51.43%
53 $4,000
Q4 2021

Jan 12, 2022
BUY
$135.05 - $182.59 $945 - $1,278
7 Added 25.0%
35 $5,000
Q2 2021

Jul 13, 2021
BUY
$134.22 - $202.37 $3,758 - $5,666
28 New
28 $5,000
Q1 2021

Apr 30, 2021
BUY
$140.25 - $196.86 $0 - $0
0 New
0 $0
Q4 2020

Jan 25, 2021
SELL
$126.47 - $163.7 $1,264 - $1,637
-10 Closed
0 $0
Q3 2020

Oct 29, 2020
BUY
$87.44 - $125.0 $874 - $1,250
10 New
10 $1,000
Q2 2020

Aug 05, 2020
BUY
$58.39 - $89.31 $0 - $0
0 New
0 $0
Q1 2020

May 12, 2020
SELL
$51.57 - $106.62 $30,942 - $63,972
-600 Closed
0 $0
Q4 2019

Jan 17, 2020
BUY
$46.07 - $79.54 $27,642 - $47,724
600 New
600 $47,000

Others Institutions Holding TXG

# of Institutions
291
Shares Held
94.7M
Call Options Held
263K
Put Options Held
85.1K
View Full List

About 10x Genomics, Inc.

TXG Quotes by TradingView
  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.43B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email